The Ekso GT™ is a robotic exoskeleton for comprehensive gait therapy which provides a superior rehabilitation experience for patients and therapists alike. The Ekso GT™ is a tool to supplement professional physiotherapists, not replace them. The use of this exoskeleton allows for a greater number of consistent steps with the appropriate weight shift to be conducted in every rehabilitation session.
The Ekso GT is approved by the FDA for use with:
- hemiplegia due to stroke
- SCI at levels of T4 to L5 and levels of T3 to C7
Design features of the Ekso GT:
- Acuated powered hip-knee exoskeleton
- Variable Assist controls, the Esko GT can apply power from 0 to 100% as needed on a step by step basis.
- Adjustable on the fly assistance level and operation mode
- Encourages correct body posture
- Integrated tether attachment for stability with extreme mobility and/or balance impairment.
- Ability for the device to recalculated assistance based on gait data gathered after each step the rehabilitation participant takes.
- Compatible for use in a therapeutic environment by patients with mobility impairment due to spinal cord injury up to C7 complete.
- Has different integrated control modes:
- spotter activated
- user activated (button on crutches or walker)
- activated upon user completing weight shift
- body shift and initiation of forward leg movement
- body shift, initiation of forward leg movement and dynamic variable assist from 0 to 100% (the Ekso GT will provide only the necessary power to finish the step).
Exoskeleton Report articles featuring Ekso Bionics (Richmond, CA, USA): Ekso Bionics
Exoskeleton Report does not endorse one exoskeleton product over another. The exoskeleton catalog is purely for educational purposes. The catalog is meant to provide an easily accessible birds-eye view of the exoskeleton industry, and a quick method to sort exoskeletons by type and purpose. All prices are approximate and are meant to provide a general sense of the cost of the devices.